Coloplast announced in a press release that it was planning to allocate one billion in Danish Krone (DKK), which converts to over $180 million, as a legal fund to be used for transvaginal mesh lawsuits. The transvaginal mesh manufacturer made the announcement in early May. In their press release, Coloplast stated that it expects to be the target of approximately 7,000 U.S. lawsuits regarding their transvaginal mesh products.
With such a large number of transvaginal mesh lawsuits before them, Coloplast noted that their insurance coverage would not be able to cover all legal expenses, which is the reason for establishing the reserve.
In their announcement, Coloplast also expressed their willingness to negotiate settlements.
An experienced defective medical device law firm with headquarters in St. Louis, Carey Danis & Lowe is a dedicated legal representative of victims who have been injured by pharmaceutical products. If you believe that you have been injured by transvaginal mesh, our defective medical device lawyers would like to evaluate your case with you.
We offer free initial case evaluations.
Contact Carey Danis & Lowe today. Reach our law offices by phone at 800.721.2519, or submit a personal injury claim form.Defective Medical Device litigation, Transvaginal Mesh